EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multiparametric MRI for assessing residual tumors in patients with muscle-invasive bladder cancer after neoadjuvant treatment: a reliable tool for guiding bladder preservation

Qian Cai, Li Tian, Lingmin Kong, Keyi Zhang, Bei Weng, Bin Huang, Yan Guo, Jun-Xing Chen, Huanjun Wang

European Radiology · 2025

DOI: 10.1007/s00330-025-11773-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Radiology, 2025. Verfasst von Qian Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoadjuvant Therapy, Multiparametric Magnetic Resonance Imaging, Neoplasm, Residual. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Medical Innovation and Practice Research Program of Guangzhou, Natural Science Outstanding Youth Fund Project of Guangdong province,China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the clinical utility of multiparametric MRI in differentiating pathological stages (ypT0 vs ypT1-4) in patients with muscle-invasive bladder cancer (MIBCa) following neoadjuvant therapy (NAT). MATERIALS AND METHODS: In this double-center cohort study, post-NAT multiparametric MRI in all consecutive patients who underwent surgery after NAT was analyzed. Two experienced radiologists independently evaluated the MRI features obtained after NAT. The post-NAT yT stage was assigned based on T2-weighted diffusion-weighted imaging (T2DWI) and on contrast-enhanced MRI scans. The diagnostic accuracies for distinguishing post-NAT ypT0 from ypT1-4 tumors with the two protocols were evaluated. Cohen's kappa (κ) statistics were used to evaluate the consistency between readers for the post-NAT yT stage. RESULTS: A total of 149 patients (mean age, 62 years ± 10 [SD]; 131 men) from two institutions were enrolled. The area under the receiver operating characteristic curve of the contrast-enhanced MRI protocol in predicting post-NAT ypT0 stage was 0.84 (95% CI: 0.77, 0.91), which was better than that of the T2DWI protocol (0.75; 95% CI: 0.67, 0.81; p = 0.002). The interobserver agreement was excellent for both the T2DWI protocol (κ = 0.89) and the contrast-enhanced MRI protocol (κ = 0.85). CONCLUSIONS: Multiparametric MRI, particularly contrast-enhanced MRI, demonstrated superior accuracy in identifying ypT0 status following NAT in MIBCa, establishing it as an essential diagnostic tool for guiding bladder preservation in clinical decision-making. KEY POINTS: Question Accurately identifying pathological complete response (ypT0) after NAT is essential for selecting bladder-preservation strategies, yet remains clinically challenging. Findings Post-treatment contrast-enhanced MRI accurately identified ypT0 status with an AUC of 0.84 and excellent inter-reader agreement, outperforming T2DWI. Clinical relevance Contrast-enhanced MRI is a reliable, non-invasive method for detecting complete tumor response after NAT, enabling better patient selection for bladder-sparing approaches and potentially improving quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeoadjuvant TherapyMultiparametric Magnetic Resonance ImagingNeoplasm, ResidualHumansMaleFemaleMiddle AgedNeoplasm InvasivenessAgedContrast MediaNeoplasm StagingReproducibility of ResultsRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

Bladder cancerMultiparametric MRITherapeutic response

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Department of Urology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. gyan@mail.sysu.edu.cn.
  • Department of Urology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. chenjunx@mail.sysu.edu.cn.
  • Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. wanghj45@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Youth Medical Innovation and Practice Research Program of Guangzhou
  • Natural Science Outstanding Youth Fund Project of Guangdong province,China

Zitieren

APA

Cai, Q., Tian, L., Kong, L., Zhang, K., Weng, B., Huang, B., Guo, Y., Chen, J. X., & Wang, H. (2025). Multiparametric MRI for assessing residual tumors in patients with muscle-invasive bladder cancer after neoadjuvant treatment: a reliable tool for guiding bladder preservation. European Radiology. https://doi.org/10.1007/s00330-025-11773-0

Vancouver

Cai Q, Tian L, Kong L, Zhang K, Weng B, Huang B, et al. Multiparametric MRI for assessing residual tumors in patients with muscle-invasive bladder cancer after neoadjuvant treatment: a reliable tool for guiding bladder preservation. European Radiology. 2025. doi:10.1007/s00330-025-11773-0

BibTeX
@article{Cai2025,
  author = {Cai, Qian and Tian, Li and Kong, Lingmin and Zhang, Keyi and Weng, Bei and Huang, Bin and Guo, Yan and Chen, Jun-Xing and Wang, Huanjun},
  title = {Multiparametric MRI for assessing residual tumors in patients with muscle-invasive bladder cancer after neoadjuvant treatment: a reliable tool for guiding bladder preservation},
  journal = {European Radiology},
  year = {2025},
  doi = {10.1007/s00330-025-11773-0}
}
Kostenlos starten →